Ultra-High Dose Drug Slows Functional Decline in Early ALS

An ultra-high dose of methylcobalamin slows functional decline and is safe in patients with early stage amyotrophic lateral sclerosis, results from a new phase 3 study suggest.
Medscape Medical News